Millbrae, CA, United States of America

John Chant

This inventor holds 1 USPTO granted patent and 5 published patent applications and 3 EPO patents. Top assignee: Genentech, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Chant. Retrieved from https://idiyas.com/inventor/john-chant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John Chant

Introduction

John Chant is a notable inventor based in Millbrae, California. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancers. His work is characterized by a focus on the FGFR2 gene, which plays a crucial role in cancer development.

Latest Patents

John Chant holds one patent titled "Methods and compositions for the diagnosis and treatment of cancer." This patent provides innovative methods and compositions aimed at diagnosing and treating colorectal cancers associated with the amplification or overexpression of the FGFR2 gene. His research has the potential to improve treatment outcomes for patients suffering from this type of cancer.

Career Highlights

Chant is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to cancer research.

Collaborations

Some of his notable coworkers include Anthony S. Guerrero and Peter Haverty. Their collaborative efforts have likely contributed to the advancements in cancer treatment methodologies.

Conclusion

John Chant's innovative work in cancer research exemplifies the impact that dedicated inventors can have on medical science. His contributions continue to pave the way for new diagnostic and treatment options for colorectal cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…